Page last updated: 2024-08-23

cabergoline and paricalcitol

cabergoline has been researched along with paricalcitol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ciebiera, M; Jakiel, G; Męczekalski, B; Słabuszewska-Jóźwiak, A; Wojtyła, C; Łukaszuk, K1

Reviews

2 review(s) available for cabergoline and paricalcitol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Alternative Oral Agents in Prophylaxis and Therapy of Uterine Fibroids-An Up-to-Date Review.
    International journal of molecular sciences, 2017, Dec-01, Volume: 18, Issue:12

    Topics: Administration, Oral; Antineoplastic Agents; Aromatase Inhibitors; Cabergoline; Catechin; Ergocalciferols; Ergolines; Female; Humans; Hydrocarbons, Fluorinated; Leiomyoma; Pyrimidines; Quality of Life; Uterine Neoplasms; Vitamin D

2017